Erratum: Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review [SpringerPlus, 1, 8, (2012), DOI 10.1186/2193-1801-1-83];Seventeen years after BRCA1: What is the BRCA mutation status of the breast cancer patients in africa? - A systematic review

SpringerPlus

Volumn 1, Issue 1, 2012, Pages 1-8

  Oluwagbemiga, Lawal AbdulRazzaq ^a   Oluwole, Atoyebi ^a   Kayode, Adesunkanmi AbdulRasheed ^b  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Africa; BRCA1; BRCA2; Breast cancer; Gene mutations; Systematic review

Indexed keywords

EID: 84876454055     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-015-1105-5     Document Type: Erratum

References (32)

1. Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA (2006) The severity, outcome and challenges of breast cancer in Nigeria. Breast 15(3):399-409. doi:S0960-9776(05)00140-2[pii].10.1016/j.breast.2005.06.008
2. Awadelkarim KD, Aceto G, Veschi S, Elhaj A, Morgano A, Mohamedani AA, Eltayeb EA, Abuidris D, Di Gioacchino M, Battista P, Verginelli F, Cama A, Elwali NE, Mariani-Costantini R (2007) BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat 102(2):189-199. doi:10.1007/s10549-006-9303-z
3. Balci A, Huusko P, Paakkonen K, Launonen V, Uner A, Ekmekci A, Winqvist R (1999) Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer. Eur J Cancer 35(5):707-710. doi:S0959804999000143[pii]
4. Bertwistle D, Swift S, Marston NJ, Jackson LE, Crossland S, Crompton MR, Marshall CJ, Ashworth A (1997) Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res 57(24):5485-5488
5. Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH (1996) BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56(14):3168-3172
6. Cherbal F, Bakour R, Adane S, Boualga K, Benais-Pont G, Maillet P (2010) BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families. Dis Markers 28(6):377-384. doi:BU18P1H3N800291V[pii].10.3233/DMA-2010-0718
7. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani SR, Ormiston W, Daly PA, Ford D, Easton DF et al (1995) Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10(8):1673-1675
8. de la Hoya M, Gutierrez-Enriquez S, Velasco E, Osorio A, Sanchez de Abajo A, Vega A, Salazar R, Esteban E, Llort G, Gonzalez-Sarmiento R, Carracedo A, Benitez J, Miner C, Diez O, Diaz-Rubio E, Caldes T (2006) Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer. Clin Chem 52(8):1480-1485. doi:clinchem.2006.070110[pii].S0007092000913326[pii]
9. Deng CX (2006) BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34(5):1416-1426. doi:34/5/1416[pii]10.1093/nar/gkl010
10. Engert S, Wappenschmidt B, Betz B, Kast K, Kutsche M, Hellebrand H, Goecke TO, Kiechle M, Niederacher D, Schmutzler RK, Meindl A (2008) MLPA screening in the BRCA1 gene from 1, 506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat 29(7):948-958. doi:10.1002/humu.20723
11. Fackenthal JD, Sveen L, Gao Q, Kohlmeir EK, Adebamowo C, Ogundiran TO, Adenipekun AA, Oyesegun R, Campbell O, Rotimi C, Akang EE, Das S, Olopade OI (2005) Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J Med Genet 42(3):276-281. doi:42/3/276[pii].10.1136/jmg.2004.020446
12. Ferla R, Calo V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V, Russo A (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18(Suppl 6):vi93-vi98. doi:18/suppl_6/vi93[pii].10.1093/annonc/mdm234
13. Gao Q, Adebamowo CA, Fackenthal J, Das S, Sveen L, Falusi AG, Olopade OI (2000) Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer. Hum Genet 107(2):192-194
14. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250(4988):1684-1689
15. IARC (2011) GLOBOCAN 2008 Cancer Incidence, Mortality and Prevalence Worldwide in 2008. World Health Organisation, http://globocan.iarc.fr/factsheet.asp. Accessed 31st December, 2011
16. Linger RJ, Kruk PA (2010) BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications. FEBS J 277(15):3086-3096. doi:EJB7735 [pii].10.1111/j.1742-4658.2010.07735.x
17. Mahfoudh W, Bouaouina N, Ahmed SB, Gabbouj S, Shan J, Mathew R, Uhrhammer N, Bignon YJ, Troudi W, Elgaaied AB, Hassen E, Chouchane L (2011) Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. Mol Biol Rep. doi:10.1007/s11033-011-0829-8
18. Masri MA, Abdel Seed NM, Fahal AH, Romano M, Baralle F, El Hassam AM, Ibrahim ME (2002) Minor role for BRCA2 (exon11) and p53 (exon 5-9) among Sudanese breast cancer patients. Breast Cancer Res Treat 71(2):145-147
19. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66-71
20. Montagna M, Dalla Palma M, Menin C, Agata S, De Nicolo A, Chieco-Bianchi L, D'Andrea E (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12(9):1055-1061
21. Oldenburg RA, Meijers-Heijboer H, Cornelisse CJ, Devilee P (2007) Genetic susceptibility for breast cancer: how many more genes to be found? Crit Rev Oncol Hematol 63(2):125-149. doi:S1040-8428(06)00249-6[pii]10.1016/j.critrevonc.2006.12.004
22. Ozdag H, Tez M, Sayek I, Muslumanoglu M, Tarcan O, Icli F, Ozturk M, Ozcelik T (2000) Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients. Eur J Cancer 36(16):2076-2082. doi:S0959-8049(00)00277-X[pii]
23. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L, Fourquet A, Salmon RJ, Clough KB, Pouillart P, Bonaiti-Pellie C, Thomas G (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet 60(5):1021-1030
24. Troudi W, Uhrhammer N, Sibille C, Dahan C, Mahfoudh W, Bouchlaka Souissi C, Jalabert T, Chouchane L, Bignon YJ, Ben Ayed F, Ben Ammar Elgaaied A (2007) Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia. J Hum Genet 52(11):915-920. doi:10.1007/s10038-007-0195-5
25. Uhrhammer N, Abdelouahab A, Lafarge L, Feillel V, Ben Dib A, Bignon YJ (2008) BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases. Int J Med Sci 5(4):197-202
26. van der Merwe N, Hamel N, Schneider SR, Apffelstaedt J, Wijnen J, Foulkes W (2010) A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa. Clin Genet. doi:10.1111/j.1399-0004.2010.01617.x
27. Whittemore AS, Gong G, Itnyre J (1997) Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 60(3):496-504
28. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789-792. doi:10.1038/378789a0
29. Yawitch TM, van Rensburg EJ, Mertz M, Falkson CI (2000) Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer. S Afr Med J 90(8):788
30. Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H (2000) BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients. Br J Cancer 83(6):737-742. doi:10.1054/bjoc.2000.1332.S0007092000913326[pii]
31. Zhang B, Fackenthal JD, Niu Q, Huo D, Sveen WE, DeMarco T, Adebamowo CA, Ogundiran T, Olopade OI (2009) Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry. Fam Cancer 8(1):15-22. doi:10.1007/s10689-008-9205-9
32. Zhang J, Fackenthal JD, Huo D, Zheng Y, Olopade OI (2010) Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population. Breast Cancer Res Treat 124(2):573-577. doi:10.1007/s10549-010-1006-9